oral liposomal compounded glp-1/gip GLP-1 Not all “GLP-1 pills” are

Chew the gummy well before swallowing it

As of October 2024, nearly 68 percent of insured people in Massachusetts had public or private plans that covered medications to treat obesity the highest share of any state, according to a report by the Robert Wood Johnson Foundation, a prominent philanthropy

When two pills are competing on nuanced clinical grounds, the ability to communicate that differentiation clearly to physicians and payers is critical, and demand for MSLs who understand the GLP-1 mechanism, the trial data, and the competitive landscape is only going to grow as more products enter the market

doi:10.1016/j.phrs.2021.105840

Telehealth has accelerated this redistribution of prescribing authority